Ibuprofen is the most widely used of all non-steroidal anti-inflammatory drugs (NSAIDs) in France. This ban on promotion in the media was decided after "an overall analysis of all advertising" around specialties based on 400 mg.
Paractemol also remains favored: around 600 million boxes sold in 2022 compared to around 34 million boxes of ibuproen (all dosages), including 30 million of ib uprofen 400 and 4 million of Ibuproens 200.